Home » St. Jude Makes Progress on Warning, Sees CRM Growth in Fourth Quarter
St. Jude Makes Progress on Warning, Sees CRM Growth in Fourth Quarter
St. Jude’s Sylmar, Calif., plant, which makes most of its CRM products, should soon emerge from an FDA warning letter, CEO Dan Starks said on the company’s earnings call last month.
The GMP Letter
Devices Inspections and Audits Quality Regulatory AffairsThe GMP Letter
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May